Wave Life Sciences Hits Day Low of $6.72 Amid Price Pressure
Wave Life Sciences has faced notable volatility, with a significant stock decline today and a 15.16% drop over the past week. Financial metrics indicate challenges, including a 44.54% decrease in net sales and a negative operating cash flow. The company continues to struggle in the pharmaceuticals sector.
Wave Life Sciences has experienced significant volatility today, with the stock declining by 10.31% as it reached an intraday low of USD 6.72. This performance marks a stark contrast to the S&P 500, which has seen a slight increase of 0.13% on the same day. Over the past week, Wave Life Sciences has faced a 15.16% drop, while its monthly performance shows a decrease of 7.24%. In the past year, the stock has underperformed considerably, with a decline of 57.12%, compared to the S&P 500's gain of 12.65%. Year-to-date, the stock is down 43.01%, further highlighting its struggles in the current market environment.
Financial metrics reveal a challenging landscape for Wave Life Sciences, with net sales for the first half of the year at USD 17.87 million, reflecting a decline of 44.54%. The company reported an operating cash flow of USD -201.93 million, indicating financial strain. Additionally, the pre-tax profit for the most recent quarter was USD -50.47 million, down 53.29%. With a market capitalization of USD 1,206 million, Wave Life Sciences continues to navigate a difficult period in the pharmaceuticals and biotechnology sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
